Literature DB >> 10218856

Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia.

C Dufour1, S Dallorso, L Casarino, A Corcione, V Pistoia, A Bacigalupo, G Morreale, G Dini.   

Abstract

A 14-year-old patient with acquired very severe aplastic anemia (VSAA) underwent bone marrow transplantation (BMT) from his HLA-identical brother. Preparative therapy was cyclophosphamide (CY) 200 mg/kg over 4 days. GVHD prophylaxis was with cyclosporin A (CsA) for a year. After an 8 year follow-up during which the patient was well with normal blood counts, graft failure occurred. At this time marrow chimerism studies demonstrated that 85% of hemopoiesis was of recipient origin. The patient was re-engrafted from the same donor after conditioning with CY 200 mg/kg over 4 days plus rabbit antithymocyte globulin (ATG) 3.5 mg/kg/day for 3 days. After 140 days follow-up he has a normal blood count. The possible causes of the graft failure are discussed. This case demonstrates that, although rarely, very late graft failure may occur after BMT for AA and highlights the need for long-term monitoring even in apparently successfully transplanted patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218856     DOI: 10.1038/sj.bmt.1701652

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  2 in total

Review 1.  The diagnosis and treatment of aplastic anemia: a review.

Authors:  Maurizio Miano; Carlo Dufour
Journal:  Int J Hematol       Date:  2015-04-03       Impact factor: 2.490

2.  Recurrent aplastic anemia with donor-type aplasia: A rare occurrence in the Indian subcontinent.

Authors:  A Majumder; S Misra; V Kumar
Journal:  J Postgrad Med       Date:  2021 Oct-Dec       Impact factor: 1.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.